Pandion Therapeutics (PAND) News Today → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free PAND Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck (MRK) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 25 at 4:15 PMEx-FBI Trainee Gets 15 Months for Trading on Girlfriend’s Infobloomberg.com - March 13 at 6:48 PMMallinckrodt plc: Mallinckrodt Announces Board of Directors and Leadership Updatesfinanznachrichten.de - February 2 at 12:32 PMVC funding update: Which Boston-area startups raised money in December?bizjournals.com - January 4 at 2:17 PMFormer Pandion exec's new startup launches with $213M for gene-editingbizjournals.com - December 12 at 2:17 PMBiogen vet's new startup raises nine-figure round, moves to Watertownbizjournals.com - December 4 at 7:37 AMAptevo Therapeutics Inc APVOmorningstar.com - November 1 at 9:46 AMFormer Fox Chase Cancer Center leader and current Wistar CEO target $10M for new venturebizjournals.com - September 19 at 5:13 AMSarepta Therapeutics FDA Panel Live Blogthestreet.com - June 10 at 7:31 AMAgile Therapeutics Stock (NASDAQ:AGRX), Quotes and News Summarybenzinga.com - January 11 at 1:24 PMGet to know the BostInno Fire Awards life sciences honoreesbizjournals.com - November 22 at 3:07 PMCybrexa Therapeutics Presents Findings from First-in-Human Study of CBX-12 as a Plenary Oral Presentation at 34th EORTC-NCI-AACR Symposiumfinance.yahoo.com - November 21 at 9:51 PMTour the latest co-laboratory space in LabCentral's networkbizjournals.com - October 24 at 6:04 AMJo Viney aims to be 'proactive and decisive' in allocating her timebizjournals.com - October 5 at 6:04 PMOptimus Healthcare Services, Inc. Appoints John P. Sganga Chair of the Board of Directors and Chief Executive Officer of Optimusstockhouse.com - September 20 at 9:48 PMSelecta Biosciences: A Derivative Play On Gene Therapies Via ImmTOR Platformseekingalpha.com - August 21 at 1:04 PMSonoma Biotherapeutics Expands Board of Directors with Appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPHfinance.yahoo.com - August 17 at 9:47 AMEx-Goldman banker tipped squash buddy on deals, US allegesafr.com - July 25 at 11:30 PMEx-U.S.congressman among 9 accused of insider tradingmsn.com - July 25 at 6:29 PMSEC charges 10 people with insider trading in four cases (update)seekingalpha.com - July 25 at 6:29 PMFormer congressman among nine charged with insider tradingmsn.com - July 25 at 6:29 PMProsecutors say FBI trainee stole tips from lawyer-girlfriend to trade on Merck dealreuters.com - July 25 at 6:29 PMEx-Congressman Stephen Buyer, FBI trainee indicted for insider tradingnypost.com - July 25 at 1:29 PMInvestment banker, ex-FBI trainee charged with insider tradingmsn.com - July 25 at 1:29 PMMerck to hire another 100 at newly expanded Cambridge research labbizjournals.com - May 25 at 5:48 PMVentus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officerfinance.yahoo.com - May 2 at 8:19 AMThese 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyondmsn.com - April 25 at 12:34 PMStartup tackling autoimmune disease launches with $101M in venture capital fundingbizjournals.com - February 9 at 4:06 PMPandion Therapeutics Holdco Llc (PAND)investing.com - January 5 at 9:11 AMMission BioCapital Boosts Team to Support Investments From New Fundfinance.yahoo.com - December 8 at 9:53 AMModerna millionaires and the double-edged sword of stock market richesmsn.com - November 7 at 9:43 AMModerna millionaires and the doubled-edged sword of stock market richesmsn.com - November 6 at 7:03 PMDeparted Moderna chief medical officer jumps to OrbiMedbizjournals.com - November 1 at 3:47 PMMarché Health Launches Digital Health Marketplace and Community with 350 Vetted Solutions to Startfinance.yahoo.com - October 5 at 9:55 AMFour firms shape Merck’s $11.5 bln bet on drugmaker Acceleronreuters.com - September 30 at 4:10 PMMerck weighed down by charges in Q2, but drug sales reboundsfgate.com - July 29 at 1:59 PMMerck Announces Second-Quarter 2021 Financial Resultsbenzinga.com - July 29 at 8:58 AMMerck stock slips after adjusted profit matches expectations, while revenue beatsmorningstar.com - July 29 at 8:58 AM Get Pandion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PAND and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. PAND Media Mentions By Week PAND Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PAND News Sentiment▼0.000.41▲Average Medical News Sentiment PAND News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PAND Articles This Week▼00▲PAND Articles Average Week Get Pandion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PAND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GPCR News Today SDGR News Today NAMS News Today SNDX News Today CPRX News Today HRMY News Today AMRX News Today RNA News Today AVDL News Today AGIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PAND) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pandion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
